MyomoMYO
About: Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
Employees: 106
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
3,800% more call options, than puts
Call options by funds: $39K | Put options by funds: $1K
117% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 6
14% more capital invested
Capital invested by funds: $32.5M [Q1] → $37.2M (+$4.63M) [Q2]
5.21% more ownership
Funds ownership: 34.93% [Q1] → 40.14% (+5.21%) [Q2]
0% more funds holding
Funds holding: 34 [Q1] → 34 (+0) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Ascendiant Capital Edward Woo 30% 1-year accuracy 14 / 46 met price target | 125%upside $8.50 | Buy Maintained | 19 Aug 2024 |
HC Wainwright & Co. Sean Lee 30% 1-year accuracy 6 / 20 met price target | 98%upside $7.50 | Buy Maintained | 12 Aug 2024 |
Craig-Hallum Craig Knickerbocker 0% 1-year accuracy 0 / 1 met price target | 85%upside $7 | Buy Initiated | 31 Jul 2024 |